ArticleFrontiers in pain research (Lausanne, Switzerland)2026
Beyond the skin surface: untangling sensitive skin syndrome and peripheral neuropathy through an exploratory real-world data analysis.
Article in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sensitive skin syndrome (SSS) is commonly reported despite its nonspecific definition, whereas peripheral neuropathy (PN) remains underrecognized in the general population. Because localized paresthesia and numbness-particularly in the hands and feet-may be perceived as skin problems, some patients reporting sensitive skin could have unrecognized neuropathy. This exploratory real-world evidence study investigated the potential overlap between SSS and PN. Methods: Patient-level real-world data from health records of individuals reporting sensitive skin were analyzed to characterize associated diagnoses, symptoms, comorbidities, and risk factors potentially related to PN. Results: Diagnoses among patients reporting sensitive skin included dermatitis (44%), altered skin sensation (33%), dry skin or urticaria (15%), and acne (13%). Within the group diagnosed with altered skin sensation, 18% reported paresthesia or tingling, 11% reported anesthesia or numbness, and 4% reported other symptoms. Documented comorbidities and risk factors included established contributors to PN, such as diabetes, cardiovascular disease, and smoking. Discussion: The findings suggest a potential diagnostic overlap between SSS and PN and raise the hypothesis that some patients with altered skin sensation may have unrecognized PN. They also demonstrate how real-world data can reveal symptom patterns that may be overlooked during routine clinical assessment. Because the hypothesis arose from the same dataset used to explore it, these findings should be considered hypothesis-generating and require prospective confirmation. Nevertheless, timely differentiation between SSS and PN could facilitate appropriate clinical evaluation and improve patient health and well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.